BioRem Inc.
3.67CAD
-0.0400 (-1.08%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BRM.V.
| In CAD M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|
| Revenue | 16 | 7 | 17 | 11 | 9 | — |
| Cost of Revenue | 11 | 5 | 11 | 8 | 7 | — |
| Gross Profit | 5 | 1 | 6 | 3 | 3 | — |
| Operating Income | 3 | 0 | 4 | 2 | 1 | — |
| Net Income | 2 | 0 | 3 | 1 | 1 | — |
| EPS (Diluted) | CA$0.10 | CA$0.01 | CA$0.16 | CA$0.06 | CA$0.04 | CA$0.00 |
Source: Yahoo Finance (limited history)